BEST PRACTICES IN: The Use of XERESE® (acyclovir and hydrocortisone) Cream 5%/1% to Help Reduce the Likelihood of Progression to Ulcerative Cold Sores

November 8, 2013|Dermatology News
Author and Disclosure Information

 

 

Medical Education Library

A supplement to Skin & Allergy News. This supplement was sponsored by Medicis, a division of Valeant Pharmaceuticals.

Topics
  • Herpes Simplex Virus-1: Prevalence and Diagnosis
  • HSL Treatment
  • XERESE® (acyclovir and hydrocortisone) Cream 5%/1%
  • Summary and Conclusions
  • INDICATION
  • IMPORTANT SAFETY INFORMATION

Faculty/Faculty Disclosure

,

Joseph Fowler, MD
University of Louisville
Louisville, Kentucky

Dr. Fowler reported that he is a member of the speakers’ bureau for Valeant Pharmaceuticals and received compensation from Valeant for his assistance in developing the content of this article.

LINKS: Click Here for PDF.

Copyright © by Frontline Medical Communications Inc.